Pronefra^®  ­- a unique 4-in-1 product to aid in the management of CKD with proven palatability

Virbac has launched Pronefra^®, a unique 4-in-1 product to aid in the management of cats and dogs with CKD. Pronefra helps to manage a range of factors which are known to decrease quality and/or length of life.

Pronefra's primary mode of activity is as a phosphate binder. Studies show that it can significantly decrease serum phosphate levels, it binds uraemic toxins, helps to maintain normal kidney architecture and contributes to supporting a balanced blood pressure.

Pronefra is presented in a liquid formulation for ease of use and should be mixed with food or given orally at meal times - the ability to give via a syringe makes both methods possible.  Virbac is providing a practice pack of support materials to practices, including a pet health recording book for clients to aid in compliance and other educational tools for vets, nurses and clients.

Commenting on its launch, Simon Boulton MRCVS, Marketing Manager for Companion Animals, said: "CKD causes a vicious circle of deterioration but good management can increase both the quality of life and life expectancy of affected animals. 

"We are delighted to launch Pronefra in the UK, following a 'sell-out' launch in mainland Europe, as a new option to aid in the management of CKD."